Form 4 for DNA Ginkgo Bioworks Holdings, Inc.
Accepted 2022-12-01 00:00:00 ET · period of report 2022-11-29 · accession 0000899243-22-037295 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-12-01 | 2022-11-29+ | DNA | Kelly Jason R | See remarks, Dir | S - Sale | $1.84 | -199.1K | 20.22M | -1.0% | -$367.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-11-30 | S | D | 102,676 | $1.79 | 20,119,168 | D | — | — | |
| 2 | Common | Class A Common Stock | 2022-11-29 | S | D | 96,433 | $1.90 | 20,221,844 | D | — | — |